| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 40 | 2024 | 3306 | 6.410 |
Why?
|
| Heart-Assist Devices | 30 | 2024 | 1287 | 3.800 |
Why?
|
| Extracorporeal Membrane Oxygenation | 20 | 2024 | 1481 | 2.950 |
Why?
|
| Tissue Donors | 17 | 2024 | 2392 | 2.060 |
Why?
|
| Heart Failure | 32 | 2024 | 11882 | 1.890 |
Why?
|
| Tissue and Organ Procurement | 8 | 2024 | 987 | 1.850 |
Why?
|
| Lung Transplantation | 9 | 2023 | 1310 | 1.810 |
Why?
|
| Organ Preservation | 6 | 2024 | 400 | 1.630 |
Why?
|
| Cardiac Surgical Procedures | 16 | 2024 | 3684 | 1.470 |
Why?
|
| Shock, Cardiogenic | 10 | 2023 | 709 | 1.300 |
Why?
|
| Ice | 3 | 2023 | 102 | 1.020 |
Why?
|
| Waiting Lists | 4 | 2024 | 779 | 0.980 |
Why?
|
| Brain Death | 5 | 2024 | 360 | 0.960 |
Why?
|
| Aortic Valve | 5 | 2019 | 1966 | 0.930 |
Why?
|
| Postoperative Care | 2 | 2020 | 1480 | 0.900 |
Why?
|
| Pericardiectomy | 2 | 2021 | 45 | 0.890 |
Why?
|
| Bioprosthesis | 3 | 2018 | 593 | 0.850 |
Why?
|
| Operating Rooms | 11 | 2011 | 790 | 0.820 |
Why?
|
| Urban Health | 2 | 2017 | 532 | 0.790 |
Why?
|
| Italy | 23 | 2020 | 856 | 0.740 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2020 | 80 | 0.680 |
Why?
|
| Air Pollution, Indoor | 8 | 2020 | 931 | 0.670 |
Why?
|
| Lightning | 1 | 2019 | 4 | 0.660 |
Why?
|
| Thoracic Surgery | 3 | 2021 | 727 | 0.650 |
Why?
|
| Prosthesis Design | 6 | 2020 | 2120 | 0.650 |
Why?
|
| Heart Valve Prosthesis | 4 | 2021 | 1464 | 0.620 |
Why?
|
| Air Microbiology | 5 | 2020 | 94 | 0.620 |
Why?
|
| Prosthesis Implantation | 2 | 2020 | 594 | 0.600 |
Why?
|
| Atherectomy, Coronary | 1 | 2018 | 137 | 0.590 |
Why?
|
| Myocytes, Cardiac | 10 | 2016 | 1673 | 0.590 |
Why?
|
| Retrospective Studies | 51 | 2024 | 81635 | 0.580 |
Why?
|
| Hemodynamics | 9 | 2022 | 4188 | 0.570 |
Why?
|
| Pacemaker, Artificial | 2 | 2024 | 828 | 0.570 |
Why?
|
| Myocardial Infarction | 8 | 2023 | 11513 | 0.560 |
Why?
|
| Mitral Valve | 6 | 2024 | 1473 | 0.550 |
Why?
|
| Survival Rate | 16 | 2024 | 12825 | 0.550 |
Why?
|
| Heart Diseases | 3 | 2020 | 2817 | 0.540 |
Why?
|
| Donor Selection | 1 | 2018 | 242 | 0.530 |
Why?
|
| Graft Survival | 8 | 2024 | 3904 | 0.520 |
Why?
|
| Rome | 10 | 2015 | 28 | 0.500 |
Why?
|
| Aneurysm, False | 1 | 2018 | 264 | 0.490 |
Why?
|
| Coronary Aneurysm | 1 | 2018 | 234 | 0.490 |
Why?
|
| Cardiac Valve Annuloplasty | 2 | 2024 | 51 | 0.490 |
Why?
|
| Heart | 8 | 2023 | 4425 | 0.480 |
Why?
|
| Ventricular Function, Left | 7 | 2020 | 3935 | 0.480 |
Why?
|
| Humans | 152 | 2024 | 766766 | 0.480 |
Why?
|
| Pneumococcal Vaccines | 3 | 2004 | 414 | 0.470 |
Why?
|
| Coronary Stenosis | 3 | 2018 | 803 | 0.460 |
Why?
|
| Treatment Outcome | 37 | 2024 | 65273 | 0.430 |
Why?
|
| Hospitals, University | 2 | 2015 | 572 | 0.430 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 1208 | 0.430 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2024 | 996 | 0.430 |
Why?
|
| Adult | 64 | 2024 | 223307 | 0.430 |
Why?
|
| Coronary Artery Bypass | 4 | 2021 | 2188 | 0.430 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 2505 | 0.420 |
Why?
|
| Ventricular Septal Rupture | 1 | 2013 | 17 | 0.420 |
Why?
|
| Postoperative Complications | 15 | 2024 | 15831 | 0.400 |
Why?
|
| Graft Rejection | 4 | 2018 | 4504 | 0.390 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2018 | 2143 | 0.380 |
Why?
|
| Suburban Health | 1 | 2011 | 11 | 0.380 |
Why?
|
| Registries | 8 | 2024 | 8351 | 0.370 |
Why?
|
| Critical Care | 2 | 2021 | 2714 | 0.370 |
Why?
|
| Sanitation | 1 | 2011 | 83 | 0.360 |
Why?
|
| Health Promotion | 3 | 2017 | 2209 | 0.360 |
Why?
|
| Consensus | 4 | 2021 | 3208 | 0.350 |
Why?
|
| Health Status Disparities | 1 | 2022 | 1880 | 0.350 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 424 | 0.350 |
Why?
|
| Death | 3 | 2023 | 685 | 0.350 |
Why?
|
| Heart Valve Diseases | 2 | 2019 | 1029 | 0.350 |
Why?
|
| Primary Prevention | 1 | 2017 | 1188 | 0.340 |
Why?
|
| Primary Graft Dysfunction | 4 | 2024 | 112 | 0.330 |
Why?
|
| Mass Casualty Incidents | 1 | 2012 | 178 | 0.330 |
Why?
|
| Middle Aged | 62 | 2024 | 223257 | 0.330 |
Why?
|
| Environmental Monitoring | 3 | 2011 | 1468 | 0.330 |
Why?
|
| Endocarditis | 1 | 2014 | 352 | 0.330 |
Why?
|
| Reoperation | 2 | 2019 | 4325 | 0.320 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2024 | 1414 | 0.320 |
Why?
|
| Societies, Medical | 2 | 2024 | 3957 | 0.310 |
Why?
|
| Heart Valve Prosthesis Implantation | 7 | 2024 | 1564 | 0.310 |
Why?
|
| Cardiology | 1 | 2020 | 1701 | 0.310 |
Why?
|
| Wounds and Injuries | 2 | 2012 | 2513 | 0.300 |
Why?
|
| Histocompatibility | 1 | 2009 | 327 | 0.300 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2019 | 1093 | 0.300 |
Why?
|
| Masks | 2 | 2020 | 212 | 0.300 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 811 | 0.300 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 3692 | 0.290 |
Why?
|
| Sarcoma | 1 | 2019 | 1802 | 0.290 |
Why?
|
| Salvage Therapy | 1 | 2014 | 1274 | 0.290 |
Why?
|
| Male | 71 | 2024 | 364142 | 0.270 |
Why?
|
| Regeneration | 6 | 2012 | 1520 | 0.270 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 643 | 0.260 |
Why?
|
| Length of Stay | 6 | 2024 | 6490 | 0.260 |
Why?
|
| Pneumococcal Infections | 2 | 2002 | 529 | 0.260 |
Why?
|
| Housing | 1 | 2011 | 683 | 0.260 |
Why?
|
| Sternotomy | 2 | 2019 | 134 | 0.260 |
Why?
|
| Heart Arrest | 3 | 2021 | 1516 | 0.250 |
Why?
|
| Nurses | 1 | 2015 | 2503 | 0.250 |
Why?
|
| Filtration | 3 | 2020 | 227 | 0.250 |
Why?
|
| Cardiomyopathies | 3 | 2012 | 2059 | 0.250 |
Why?
|
| Aged | 47 | 2024 | 171343 | 0.250 |
Why?
|
| Microclimate | 6 | 1996 | 11 | 0.240 |
Why?
|
| Attitude of Health Personnel | 3 | 2015 | 3927 | 0.240 |
Why?
|
| Female | 64 | 2024 | 396520 | 0.240 |
Why?
|
| Accidents, Traffic | 1 | 2010 | 818 | 0.240 |
Why?
|
| Risk Factors | 21 | 2024 | 74881 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 4056 | 0.230 |
Why?
|
| Textiles | 2 | 2020 | 43 | 0.220 |
Why?
|
| Catheter Ablation | 2 | 2014 | 2786 | 0.220 |
Why?
|
| Renal Dialysis | 1 | 2013 | 1790 | 0.220 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 2 | 2014 | 89 | 0.220 |
Why?
|
| Prognosis | 9 | 2021 | 29948 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 7431 | 0.220 |
Why?
|
| Atrial Fibrillation | 3 | 2020 | 5182 | 0.220 |
Why?
|
| Incidence | 9 | 2024 | 21525 | 0.210 |
Why?
|
| New York | 3 | 2015 | 879 | 0.210 |
Why?
|
| Hygiene | 2 | 2020 | 95 | 0.210 |
Why?
|
| Propensity Score | 2 | 2022 | 1972 | 0.210 |
Why?
|
| Walking | 1 | 2010 | 1201 | 0.210 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2001 | 133 | 0.210 |
Why?
|
| Action Potentials | 3 | 2016 | 1835 | 0.210 |
Why?
|
| Chickenpox Vaccine | 1 | 2002 | 39 | 0.200 |
Why?
|
| Stem Cells | 3 | 2011 | 3537 | 0.200 |
Why?
|
| Meningococcal Vaccines | 1 | 2002 | 96 | 0.200 |
Why?
|
| Patient Selection | 3 | 2024 | 4252 | 0.190 |
Why?
|
| Recovery of Function | 2 | 2024 | 2976 | 0.190 |
Why?
|
| Chickenpox | 1 | 2002 | 95 | 0.190 |
Why?
|
| Organ Transplantation | 2 | 2022 | 1172 | 0.190 |
Why?
|
| Heart, Artificial | 1 | 2002 | 110 | 0.190 |
Why?
|
| Echocardiography | 4 | 2024 | 5037 | 0.180 |
Why?
|
| Mitral Valve Annuloplasty | 2 | 2013 | 145 | 0.180 |
Why?
|
| Tricuspid Valve | 1 | 2024 | 419 | 0.180 |
Why?
|
| Postoperative Period | 3 | 2016 | 1824 | 0.180 |
Why?
|
| Hospitals | 4 | 2022 | 3888 | 0.180 |
Why?
|
| Scimitar Syndrome | 1 | 2020 | 30 | 0.180 |
Why?
|
| Physicians | 2 | 2015 | 4591 | 0.170 |
Why?
|
| Age Factors | 9 | 2021 | 18397 | 0.170 |
Why?
|
| United States | 13 | 2024 | 72951 | 0.170 |
Why?
|
| Time Factors | 16 | 2024 | 40149 | 0.170 |
Why?
|
| Equipment Design | 5 | 2020 | 3487 | 0.170 |
Why?
|
| Cardiotonic Agents | 1 | 2023 | 541 | 0.170 |
Why?
|
| Immunization Programs | 1 | 2002 | 267 | 0.160 |
Why?
|
| Mediastinum | 1 | 2021 | 272 | 0.160 |
Why?
|
| Calcium Signaling | 2 | 2014 | 736 | 0.160 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2002 | 312 | 0.160 |
Why?
|
| Catheterization | 1 | 2024 | 1429 | 0.160 |
Why?
|
| Organ Preservation Solutions | 1 | 2019 | 105 | 0.160 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2018 | 40 | 0.150 |
Why?
|
| Health Services Administration | 1 | 1999 | 63 | 0.150 |
Why?
|
| Influenza Vaccines | 2 | 2004 | 780 | 0.150 |
Why?
|
| Adult Stem Cells | 2 | 2011 | 221 | 0.150 |
Why?
|
| Dipyridamole | 2 | 2016 | 143 | 0.150 |
Why?
|
| Physical Examination | 1 | 2004 | 1265 | 0.150 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 418 | 0.150 |
Why?
|
| Critical Illness | 2 | 2021 | 2750 | 0.150 |
Why?
|
| Air Pollutants, Occupational | 3 | 1996 | 406 | 0.140 |
Why?
|
| Delirium | 2 | 2020 | 1698 | 0.140 |
Why?
|
| Myocardium | 4 | 2012 | 4765 | 0.140 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 92 | 0.140 |
Why?
|
| Health Occupations | 1 | 1999 | 226 | 0.140 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2012 | 361 | 0.140 |
Why?
|
| Cross Infection | 4 | 2020 | 1427 | 0.140 |
Why?
|
| Emergency Service, Hospital | 3 | 2015 | 7871 | 0.140 |
Why?
|
| Water | 1 | 2003 | 1417 | 0.140 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 1547 | 0.140 |
Why?
|
| Swine | 4 | 2022 | 5987 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2022 | 2391 | 0.140 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 39309 | 0.130 |
Why?
|
| Public Health Administration | 1 | 1999 | 242 | 0.130 |
Why?
|
| Family Practice | 2 | 1996 | 508 | 0.130 |
Why?
|
| Air Conditioning | 4 | 2020 | 54 | 0.130 |
Why?
|
| Prostheses and Implants | 2 | 2020 | 1275 | 0.130 |
Why?
|
| Meningitis, Haemophilus | 1 | 1995 | 20 | 0.130 |
Why?
|
| Transplantation, Autologous | 2 | 2019 | 2127 | 0.130 |
Why?
|
| Intensive Care Units | 2 | 2020 | 3799 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 2232 | 0.130 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 497 | 0.130 |
Why?
|
| Health Facilities | 1 | 2020 | 579 | 0.130 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 442 | 0.120 |
Why?
|
| Cold Temperature | 1 | 2019 | 794 | 0.120 |
Why?
|
| Analgesia, Epidural | 1 | 2018 | 332 | 0.120 |
Why?
|
| Perioperative Care | 2 | 2024 | 1043 | 0.120 |
Why?
|
| Ventricular Function, Right | 2 | 2018 | 629 | 0.120 |
Why?
|
| Ventricular Function | 2 | 2016 | 403 | 0.120 |
Why?
|
| Population Surveillance | 3 | 2017 | 2594 | 0.120 |
Why?
|
| Heart Defects, Congenital | 2 | 2023 | 4712 | 0.120 |
Why?
|
| Databases, Factual | 4 | 2018 | 8066 | 0.120 |
Why?
|
| Pulmonary Veins | 1 | 2020 | 758 | 0.120 |
Why?
|
| Preventive Medicine | 1 | 1996 | 246 | 0.110 |
Why?
|
| Anesthetics | 4 | 1996 | 525 | 0.110 |
Why?
|
| Accreditation | 1 | 2017 | 476 | 0.110 |
Why?
|
| Myocardial Ischemia | 4 | 2013 | 2132 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 505 | 0.110 |
Why?
|
| Safety | 2 | 2018 | 1157 | 0.110 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 613 | 0.110 |
Why?
|
| Shock | 1 | 2016 | 316 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2024 | 996 | 0.110 |
Why?
|
| Sternum | 1 | 2015 | 177 | 0.110 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 602 | 0.110 |
Why?
|
| Pulmonary Artery | 1 | 2022 | 1938 | 0.110 |
Why?
|
| Risk Assessment | 9 | 2023 | 24295 | 0.110 |
Why?
|
| Dexmedetomidine | 1 | 2018 | 321 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 1065 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2019 | 955 | 0.110 |
Why?
|
| Otitis Media, Suppurative | 1 | 2012 | 27 | 0.100 |
Why?
|
| Multivariate Analysis | 7 | 2017 | 12064 | 0.100 |
Why?
|
| Clinical Competence | 3 | 2019 | 4858 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 1292 | 0.100 |
Why?
|
| Ossicular Prosthesis | 1 | 2012 | 36 | 0.100 |
Why?
|
| Remission Induction | 1 | 2018 | 2413 | 0.100 |
Why?
|
| Environment, Controlled | 1 | 1992 | 42 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3110 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3232 | 0.100 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2012 | 45 | 0.100 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2012 | 52 | 0.100 |
Why?
|
| Anesthesia, Closed-Circuit | 1 | 1992 | 14 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2019 | 947 | 0.100 |
Why?
|
| Vaccination | 3 | 1997 | 3434 | 0.100 |
Why?
|
| Pandemics | 3 | 2020 | 8735 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2024 | 1946 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2024 | 2039 | 0.100 |
Why?
|
| Adolescent | 13 | 2021 | 88904 | 0.100 |
Why?
|
| Cell Fusion | 2 | 2009 | 294 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2014 | 832 | 0.100 |
Why?
|
| Dogs | 3 | 2016 | 3834 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 1 | 2020 | 1506 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2016 | 1721 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 6512 | 0.090 |
Why?
|
| Ephrin-A1 | 1 | 2011 | 9 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2021 | 59550 | 0.090 |
Why?
|
| Ephrin-A2 | 1 | 2011 | 25 | 0.090 |
Why?
|
| Ventilation | 3 | 2020 | 129 | 0.090 |
Why?
|
| Heart Septum | 1 | 2012 | 303 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 1033 | 0.090 |
Why?
|
| Anticoagulants | 4 | 2020 | 4855 | 0.090 |
Why?
|
| Muscle Development | 1 | 2012 | 258 | 0.090 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 12534 | 0.090 |
Why?
|
| Kidney | 3 | 2024 | 7074 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2015 | 8728 | 0.090 |
Why?
|
| Transplantation | 1 | 2012 | 222 | 0.090 |
Why?
|
| Health Services | 1 | 1995 | 755 | 0.090 |
Why?
|
| Otitis Media | 1 | 2012 | 287 | 0.090 |
Why?
|
| Hepatitis C | 1 | 2020 | 1595 | 0.090 |
Why?
|
| Prevalence | 5 | 2016 | 15835 | 0.080 |
Why?
|
| Community Health Centers | 1 | 1994 | 469 | 0.080 |
Why?
|
| Health Care Reform | 1 | 1999 | 1256 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2018 | 2253 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 1520 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 865 | 0.080 |
Why?
|
| Prosthesis-Related Infections | 1 | 2015 | 497 | 0.080 |
Why?
|
| Comorbidity | 2 | 2014 | 10580 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 1994 | 573 | 0.080 |
Why?
|
| Young Adult | 9 | 2021 | 59939 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2018 | 10100 | 0.080 |
Why?
|
| Preventive Health Services | 1 | 1994 | 571 | 0.080 |
Why?
|
| Exercise Test | 1 | 2017 | 2188 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 385 | 0.080 |
Why?
|
| Health Education | 1 | 1995 | 1060 | 0.080 |
Why?
|
| Cities | 1 | 2011 | 542 | 0.080 |
Why?
|
| Stents | 1 | 2020 | 3193 | 0.080 |
Why?
|
| Internal Medicine | 1 | 2015 | 1064 | 0.070 |
Why?
|
| Coronary Angiography | 2 | 2018 | 4508 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 1768 | 0.070 |
Why?
|
| Coronary Vessels | 2 | 2009 | 3100 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2019 | 5943 | 0.070 |
Why?
|
| Causality | 1 | 2014 | 1252 | 0.070 |
Why?
|
| Stem Cell Transplantation | 3 | 2011 | 1600 | 0.070 |
Why?
|
| Pericardium | 1 | 2012 | 681 | 0.070 |
Why?
|
| Pneumonia | 1 | 1999 | 2159 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2011 | 2062 | 0.070 |
Why?
|
| Stroke | 2 | 2020 | 9741 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 1604 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1389 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2020 | 20708 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2017 | 1417 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 10384 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2019 | 3070 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2017 | 1389 | 0.070 |
Why?
|
| Child | 13 | 2021 | 80668 | 0.070 |
Why?
|
| Proteomics | 1 | 2020 | 3914 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 2188 | 0.070 |
Why?
|
| Aspirin | 2 | 2016 | 3135 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 2023 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2013 | 2258 | 0.070 |
Why?
|
| Mothers | 1 | 1997 | 2208 | 0.060 |
Why?
|
| Humidity | 2 | 2020 | 206 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2024 | 41710 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2016 | 2763 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2014 | 1390 | 0.060 |
Why?
|
| Vasopressins | 2 | 1997 | 358 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 1320 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2418 | 0.060 |
Why?
|
| Animals | 13 | 2024 | 168930 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3001 | 0.060 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2020 | 1097 | 0.060 |
Why?
|
| Travel | 1 | 1991 | 806 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 1145 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 1991 | 857 | 0.060 |
Why?
|
| Antimalarials | 1 | 1991 | 909 | 0.060 |
Why?
|
| Prospective Studies | 8 | 2024 | 54871 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15908 | 0.060 |
Why?
|
| Heart-Lung Transplantation | 1 | 2024 | 87 | 0.060 |
Why?
|
| Water Pollution | 1 | 2003 | 31 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2016 | 3464 | 0.050 |
Why?
|
| Child, Preschool | 9 | 2019 | 42577 | 0.050 |
Why?
|
| Warfarin | 3 | 2020 | 1494 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 1424 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8045 | 0.050 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2004 | 136 | 0.050 |
Why?
|
| Hepacivirus | 2 | 2020 | 1343 | 0.050 |
Why?
|
| Risk | 1 | 2015 | 9602 | 0.050 |
Why?
|
| Water Microbiology | 1 | 2003 | 117 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 1126 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2024 | 222 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2024 | 282 | 0.050 |
Why?
|
| Ventricular Remodeling | 2 | 2024 | 1281 | 0.050 |
Why?
|
| Hospital Mortality | 3 | 2021 | 5343 | 0.050 |
Why?
|
| Public Health | 2 | 2011 | 2681 | 0.050 |
Why?
|
| Thrombosis | 1 | 2016 | 2953 | 0.050 |
Why?
|
| Heart Ventricles | 2 | 2013 | 3832 | 0.050 |
Why?
|
| Personnel, Hospital | 1 | 2004 | 285 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2015 | 575 | 0.050 |
Why?
|
| International Normalized Ratio | 2 | 2016 | 382 | 0.050 |
Why?
|
| Sneezing | 1 | 2020 | 16 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 2020 | 1622 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2015 | 8533 | 0.050 |
Why?
|
| Medical Waste Disposal | 1 | 2020 | 14 | 0.050 |
Why?
|
| Hospital Design and Construction | 1 | 2020 | 34 | 0.040 |
Why?
|
| Equipment Safety | 1 | 2002 | 250 | 0.040 |
Why?
|
| Polypropylenes | 1 | 2020 | 63 | 0.040 |
Why?
|
| Construction Materials | 1 | 2020 | 60 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2014 | 9357 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2003 | 434 | 0.040 |
Why?
|
| Shock, Septic | 2 | 1997 | 772 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9404 | 0.040 |
Why?
|
| Cell Differentiation | 4 | 2011 | 11651 | 0.040 |
Why?
|
| Temperature | 2 | 2020 | 2233 | 0.040 |
Why?
|
| Health | 1 | 2003 | 397 | 0.040 |
Why?
|
| Heating | 1 | 2020 | 103 | 0.040 |
Why?
|
| Device Approval | 1 | 2002 | 164 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 2024 | 619 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2012 | 2416 | 0.040 |
Why?
|
| Ligation | 1 | 2020 | 446 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2013 | 5992 | 0.040 |
Why?
|
| Perfusion | 1 | 2024 | 1409 | 0.040 |
Why?
|
| Equipment Contamination | 1 | 2020 | 183 | 0.040 |
Why?
|
| Aging | 2 | 2016 | 8731 | 0.040 |
Why?
|
| France | 1 | 2020 | 495 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 3432 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2024 | 693 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2013 | 3283 | 0.040 |
Why?
|
| Base Sequence | 1 | 2009 | 12415 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 3408 | 0.040 |
Why?
|
| Living Donors | 1 | 2003 | 647 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 20144 | 0.040 |
Why?
|
| Education, Continuing | 1 | 1999 | 115 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 26310 | 0.040 |
Why?
|
| Heart Atria | 1 | 2024 | 1361 | 0.040 |
Why?
|
| Aerosols | 1 | 2020 | 634 | 0.040 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 346 | 0.040 |
Why?
|
| Infant, Newborn | 6 | 1999 | 26389 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2019 | 339 | 0.040 |
Why?
|
| Neprilysin | 1 | 2020 | 487 | 0.040 |
Why?
|
| Viremia | 1 | 2020 | 727 | 0.040 |
Why?
|
| Quinoxalines | 1 | 2019 | 297 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2018 | 271 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5887 | 0.040 |
Why?
|
| Infant | 6 | 2002 | 36461 | 0.040 |
Why?
|
| Cardiac Output | 2 | 1997 | 838 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 949 | 0.030 |
Why?
|
| Air | 1 | 1997 | 182 | 0.030 |
Why?
|
| Bacterial Vaccines | 1 | 1999 | 400 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 17608 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2020 | 992 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1997 | 6329 | 0.030 |
Why?
|
| Cough | 1 | 2020 | 599 | 0.030 |
Why?
|
| Massachusetts | 2 | 2020 | 8891 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 4215 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 1999 | 326 | 0.030 |
Why?
|
| Cardiac Output, Low | 1 | 1997 | 192 | 0.030 |
Why?
|
| Sick Building Syndrome | 1 | 1996 | 17 | 0.030 |
Why?
|
| Forecasting | 2 | 2004 | 2936 | 0.030 |
Why?
|
| Operating Room Technicians | 1 | 1996 | 15 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 2021 | 538 | 0.030 |
Why?
|
| Carotid Artery, Internal | 1 | 2018 | 440 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 1996 | 316 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 6207 | 0.030 |
Why?
|
| Infection Control | 1 | 2003 | 984 | 0.030 |
Why?
|
| Air Pollutants | 1 | 1990 | 2931 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 2004 | 1456 | 0.030 |
Why?
|
| Coronary Artery Disease | 2 | 2013 | 6558 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 6850 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3792 | 0.030 |
Why?
|
| Genotype | 1 | 2009 | 13036 | 0.030 |
Why?
|
| Sex Distribution | 1 | 1999 | 2274 | 0.030 |
Why?
|
| Respiration | 1 | 2020 | 1654 | 0.030 |
Why?
|
| Gallium Radioisotopes | 1 | 2015 | 195 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2019 | 862 | 0.030 |
Why?
|
| Education | 1 | 1997 | 531 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2018 | 676 | 0.030 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1997 | 291 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 1999 | 764 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1997 | 654 | 0.030 |
Why?
|
| Nitrous Oxide | 1 | 1994 | 166 | 0.030 |
Why?
|
| Workload | 1 | 2019 | 849 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3430 | 0.030 |
Why?
|
| Age Distribution | 1 | 1999 | 2869 | 0.030 |
Why?
|
| Gases | 1 | 1994 | 205 | 0.030 |
Why?
|
| New York City | 1 | 2016 | 736 | 0.030 |
Why?
|
| Stroke Volume | 2 | 2020 | 5618 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2013 | 164 | 0.030 |
Why?
|
| Bone Banks | 1 | 2012 | 4 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2019 | 2085 | 0.030 |
Why?
|
| Vasodilation | 1 | 1997 | 969 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2013 | 148 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2012 | 74 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 4018 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2013 | 185 | 0.020 |
Why?
|
| Weight Loss | 1 | 2024 | 2712 | 0.020 |
Why?
|
| Tetanus | 1 | 1992 | 52 | 0.020 |
Why?
|
| Bone Conduction | 1 | 2012 | 102 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 1995 | 405 | 0.020 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2012 | 210 | 0.020 |
Why?
|
| Sex Factors | 2 | 2024 | 10619 | 0.020 |
Why?
|
| Inpatients | 1 | 2023 | 2565 | 0.020 |
Why?
|
| Family Characteristics | 1 | 1997 | 1002 | 0.020 |
Why?
|
| Device Removal | 1 | 2017 | 643 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2011 | 35 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 1992 | 188 | 0.020 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2011 | 22 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 2018 | 858 | 0.020 |
Why?
|
| SOXD Transcription Factors | 1 | 2011 | 44 | 0.020 |
Why?
|
| Behavior | 1 | 1994 | 538 | 0.020 |
Why?
|
| Situs Inversus | 1 | 2010 | 63 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 14072 | 0.020 |
Why?
|
| Program Evaluation | 1 | 1999 | 2504 | 0.020 |
Why?
|
| Halogens | 1 | 1990 | 13 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15657 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2011 | 820 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2783 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 271 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 1143 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2011 | 230 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2019 | 1982 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 810 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2002 | 3242 | 0.020 |
Why?
|
| Linear Models | 2 | 2016 | 5874 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2020 | 2635 | 0.020 |
Why?
|
| Atrioventricular Block | 1 | 2010 | 141 | 0.020 |
Why?
|
| Connexin 43 | 1 | 2009 | 202 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2015 | 1003 | 0.020 |
Why?
|
| Logistic Models | 2 | 2019 | 13278 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1406 | 0.020 |
Why?
|
| Gene Expression | 2 | 2011 | 7585 | 0.020 |
Why?
|
| Coronary Circulation | 2 | 2009 | 1602 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 705 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2012 | 3581 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2011 | 844 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 1516 | 0.020 |
Why?
|
| Mortality | 1 | 1999 | 2910 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 4278 | 0.020 |
Why?
|
| Bacteremia | 1 | 2015 | 987 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2010 | 477 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1337 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3618 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2010 | 956 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 547 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2013 | 18984 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 881 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 1505 | 0.020 |
Why?
|
| Transposition of Great Vessels | 1 | 2010 | 581 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 2126 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2024 | 13050 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 1396 | 0.020 |
Why?
|
| Decision Making | 1 | 2019 | 3951 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6307 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 723 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 3837 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 701 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 2795 | 0.010 |
Why?
|
| Rats | 2 | 2011 | 23717 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2020 | 6282 | 0.010 |
Why?
|
| Norepinephrine | 2 | 1997 | 898 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2011 | 3093 | 0.010 |
Why?
|
| Curriculum | 1 | 2018 | 3783 | 0.010 |
Why?
|
| Cell Separation | 1 | 2009 | 1718 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12430 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22352 | 0.010 |
Why?
|
| Infection Control Practitioners | 1 | 2003 | 12 | 0.010 |
Why?
|
| Protective Devices | 1 | 2004 | 72 | 0.010 |
Why?
|
| Cell Division | 1 | 2011 | 4474 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 1935 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1997 | 7841 | 0.010 |
Why?
|
| Heparin | 1 | 2010 | 1636 | 0.010 |
Why?
|
| Sleep | 1 | 2018 | 4815 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1884 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 2011 | 1313 | 0.010 |
Why?
|
| Hospital Bed Capacity | 1 | 2003 | 200 | 0.010 |
Why?
|
| Fees and Charges | 1 | 2003 | 189 | 0.010 |
Why?
|
| Actins | 1 | 2009 | 2060 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 1991 | 1851 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2012 | 4166 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2011 | 3641 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4047 | 0.010 |
Why?
|
| Malaria | 1 | 1991 | 1246 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6422 | 0.010 |
Why?
|
| Recurrence | 1 | 2013 | 8507 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1990 | 2141 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1990 | 2030 | 0.010 |
Why?
|
| Risk Management | 1 | 2004 | 558 | 0.010 |
Why?
|
| Hospital Administration | 1 | 2004 | 351 | 0.010 |
Why?
|
| Health Personnel | 1 | 1994 | 3384 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1646 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 2413 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2013 | 3465 | 0.010 |
Why?
|
| Prisoners | 1 | 2003 | 315 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1995 | 14762 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5199 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9547 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2010 | 6408 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22248 | 0.010 |
Why?
|
| Models, Structural | 1 | 1996 | 339 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 81889 | 0.010 |
Why?
|
| Biomedical Engineering | 1 | 1996 | 284 | 0.010 |
Why?
|
| Quality Control | 1 | 1997 | 834 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1997 | 939 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10445 | 0.010 |
Why?
|
| Epinephrine | 1 | 1997 | 782 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9525 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1756 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1997 | 1838 | 0.010 |
Why?
|
| Transients and Migrants | 1 | 1995 | 170 | 0.010 |
Why?
|
| Quality of Life | 1 | 2013 | 13476 | 0.010 |
Why?
|
| Sodium | 1 | 1997 | 1594 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18330 | 0.010 |
Why?
|
| Cattle | 1 | 1997 | 3815 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 36567 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1996 | 978 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 23619 | 0.010 |
Why?
|
| Hypertension | 1 | 1990 | 8616 | 0.010 |
Why?
|
| Dopamine | 1 | 1997 | 1581 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1996 | 1794 | 0.000 |
Why?
|
| Acute Disease | 1 | 1997 | 7241 | 0.000 |
Why?
|
| Heart Rate | 1 | 1997 | 4207 | 0.000 |
Why?
|
| Clinical Protocols | 1 | 1990 | 1437 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 4853 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1990 | 2021 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1990 | 2694 | 0.000 |
Why?
|
| Delivery of Health Care | 1 | 1995 | 5368 | 0.000 |
Why?
|